← All Sponsors
SPONSOR

The Affiliated People's Hospital of Ningbo University

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Relapsed/Refractory Hematological MalignanciesLymphomaMyelomaLeukemia
NCT05528887 Phase 1
Recruiting

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

Relapsed/Refractory Hematological Malignancies
China View Trial →